Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia Proceeds Expected to Fund Ongoing Development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback